Globe Life (NYSE:GL) Price Target Raised to $201.00

Globe Life (NYSE:GL) had its price objective hoisted by JPMorgan Chase & Co. from $181.00 to $201.00 in a research report report published on Tuesday morning,Benzinga reports. They currently have an overweight rating on the stock.

GL has been the topic of several other research reports. Jefferies Financial Group upped their target price on shares of Globe Life from $147.00 to $166.00 and gave the stock a “hold” rating in a research note on Friday, July 10th. Truist Financial raised their price target on shares of Globe Life from $180.00 to $185.00 and gave the company a “buy” rating in a research report on Friday, April 24th. TD Cowen boosted their price objective on shares of Globe Life from $199.00 to $215.00 and gave the stock a “buy” rating in a report on Tuesday, June 23rd. Weiss Ratings upgraded shares of Globe Life from a “buy (b-)” rating to a “buy (b)” rating in a report on Wednesday, May 13th. Finally, Piper Sandler increased their target price on Globe Life from $175.00 to $200.00 and gave the company an “overweight” rating in a research note on Wednesday, July 15th. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $187.60.

Globe Life Price Performance

Shares of NYSE:GL opened at $170.65 on Tuesday. The business has a fifty day moving average price of $168.70 and a 200-day moving average price of $152.76. The company has a debt-to-equity ratio of 0.38, a current ratio of 0.07 and a quick ratio of 0.07. The company has a market capitalization of $13.25 billion, a PE ratio of 11.33 and a beta of 0.47. Globe Life has a 1-year low of $123.00 and a 1-year high of $191.55.

Globe Life (NYSE:GL) last announced its quarterly earnings data on Wednesday, July 22nd. The company reported $3.61 EPS for the quarter, missing the consensus estimate of $3.67 by ($0.06). Globe Life had a net margin of 19.58% and a return on equity of 20.73%. The firm had revenue of $1.60 billion for the quarter, compared to analysts’ expectations of $1.59 billion. During the same period last year, the company posted $3.05 earnings per share. The business’s revenue for the quarter was up 8.0% compared to the same quarter last year. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS. As a group, equities analysts expect that Globe Life will post 15.64 EPS for the current fiscal year.

Globe Life Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Monday, July 6th will be issued a dividend of $0.33 per share. This represents a $1.32 annualized dividend and a dividend yield of 0.8%. The ex-dividend date of this dividend is Monday, July 6th. Globe Life’s dividend payout ratio is presently 9.13%.

Insider Transactions at Globe Life

In related news, CEO Frank M. Svoboda sold 20,000 shares of the company’s stock in a transaction on Friday, May 22nd. The stock was sold at an average price of $156.68, for a total transaction of $3,133,600.00. Following the completion of the sale, the chief executive officer owned 54,020 shares in the company, valued at approximately $8,463,853.60. This represents a 27.02% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Thomas Peter Kalmbach sold 15,637 shares of the business’s stock in a transaction dated Monday, May 11th. The shares were sold at an average price of $153.65, for a total value of $2,402,625.05. Following the sale, the chief financial officer owned 45,335 shares of the company’s stock, valued at approximately $6,965,722.75. This represents a 25.65% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last quarter, insiders have sold 90,187 shares of company stock valued at $14,299,874. Corporate insiders own 2.11% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in GL. Compound Planning Inc. lifted its position in shares of Globe Life by 4.3% during the fourth quarter. Compound Planning Inc. now owns 1,968 shares of the company’s stock valued at $275,000 after buying an additional 82 shares during the last quarter. Root Financial Partners LLC grew its position in shares of Globe Life by 23.3% in the 1st quarter. Root Financial Partners LLC now owns 439 shares of the company’s stock worth $61,000 after buying an additional 83 shares during the last quarter. Transcend Capital Advisors LLC raised its stake in shares of Globe Life by 3.9% during the 4th quarter. Transcend Capital Advisors LLC now owns 2,265 shares of the company’s stock worth $317,000 after acquiring an additional 84 shares in the last quarter. Natural Investments LLC raised its stake in shares of Globe Life by 2.6% during the 4th quarter. Natural Investments LLC now owns 3,452 shares of the company’s stock worth $482,000 after acquiring an additional 87 shares in the last quarter. Finally, Parallel Advisors LLC lifted its position in Globe Life by 5.6% during the fourth quarter. Parallel Advisors LLC now owns 1,651 shares of the company’s stock valued at $231,000 after acquiring an additional 87 shares during the last quarter. 81.61% of the stock is currently owned by institutional investors.

Globe Life News Roundup

Here are the key news stories impacting Globe Life this week:

• Positive Sentiment: Globe Life raised its FY 2026 EPS guidance to $15.55-$15.95, signaling management confidence in the business outlook. Globe Life Inc. Reports Second Quarter 2026 Results
• Positive Sentiment: Quarterly revenue rose 8% year over year to $1.60 billion, slightly ahead of estimates, helped by broad underwriting gains and stronger investment income. Insurer Globe Life’s second-quarter profit rises on strong underwriting income
• Positive Sentiment: TD Cowen raised its price target on Globe Life to $225 and kept a buy rating, reflecting a constructive view on the stock’s longer-term potential. Benzinga
• Neutral Sentiment: Net operating income was $3.61 per share, improving from $3.27 a year ago but just below the consensus estimate of $3.67. Globe Life Inc. Reports Second Quarter 2026 Results
• Negative Sentiment: Operating expenses escalated enough to pressure the quarter and contribute to the earnings miss, which may be the main reason investors are selling the stock today. Globe Life Q2 Earnings Miss Estimates on Escalating Expenses

Globe Life Company Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.